Literature DB >> 8938211

The future cancer burden as a study subject.

T Hakulinen1.   

Abstract

The various purposes of predictions of future cancer burden are outlined and divided principally into two contexts, administrative and scientific. Various difficulties in making predictions are reviewed, relating to unknown etiology of cancer, to changes in definitions, criteria and facilities, to weaknesses in the statistical base and to choice of the statistical model. Predictions made under the Nordic Action Plan against Cancer, particularly for Sweden, are given as an example. The other examples concern predictions of incidence of lung cancer and smoking in Europe and incidence of breast cancer and mammography screening in Finland.

Entities:  

Mesh:

Year:  1996        PMID: 8938211     DOI: 10.3109/02841869609083996

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  Modelling predictions of cancer deaths in Northern Ireland.

Authors:  D French; D Catney; A T Gavin
Journal:  Ulster Med J       Date:  2006-05

2.  Projection scenarios of body mass index (2013-2030) for Public Health Planning in Quebec.

Authors:  Ernest Lo; Denis Hamel; Yun Jen; Patricia Lamontagne; Sylvie Martel; Colin Steensma; Chantal Blouin; Russell Steele
Journal:  BMC Public Health       Date:  2014-09-25       Impact factor: 3.295

3.  A multi-country comparison of stochastic models of breast cancer mortality with P-splines smoothing approach.

Authors:  Sumaira Mubarik; Ying Hu; Chuanhua Yu
Journal:  BMC Med Res Methodol       Date:  2020-12-09       Impact factor: 4.615

4.  In-hospital death caused by pancreatic cancer in Spain: application with a bayesian network.

Authors:  A Alvaro-Meca; R Gil-Prieto; A Gil de Miguel
Journal:  Int J Biomed Sci       Date:  2011-06

5.  Estimation and projection of the national profile of cancer mortality in China: 1991-2005.

Authors:  L Yang; D M Parkin; L D Li; Y D Chen; F Bray
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.